Skip main navigation

  • Life Course Cardiovascular Health: Risk Factors, Outcomes, and Interventions

  • Genomic Innovation in Early Life Cardiovascular Disease Prevention and Treatment

  • Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine

  • Repurposing Drugs for the Treatment of COVID-19 and Its Cardiovascular Manifestations

  • The Lymphatic Vasculature in Cardiac Development and Ischemic Heart Disease

  • Clinical Potential of Adrenomedullin Signaling in the Cardiovascular System

  • Accelerated Vascular Aging in Chronic Kidney Disease: The Potential for Novel Therapies

  • Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease

  • Use of Computation Ecosystems to Analyze the Kidney-Heart Crosstalk

  • Ketones and the Heart: Metabolic Principles and Therapeutic Implications

  • Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents

  • Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation

  • Bioengineering Human Tissues and the Future of Vascular Replacement

  • Targeting Microtubules for the Treatment of Heart Disease

  • Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension

  • Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies